112
Participants
Start Date
September 30, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Brinzolamide 1.0% + Timolol 0.5% ophthalmic suspension
Dorzolamide 2.0% + Timolol 0.5% ophthalmic solution
Lead Sponsor
Alcon Research
INDUSTRY